Mylan CEO testified before a House panel that EpiPen prices went up because of investing upgrades, according to NBC. » Read More
Some common weight-loss drugs seem to work better than others, according to a new study in a respected medical journal.
A new device that drains a portion of a person's stomach contents after every meal, has just won approval from the U.S. Food and Drug Administration.
The major doctors group said it wants Congress to fund research into the problem.
Valeant Joseph Papa CEO met with shareholders outlining his stabilization plan to rebuild the company's reputation amid accusations.
At the same time, federal health spending would decline by more than $900 billion.
Gay Men's Health Crisis CEO Kelsey Louie criticizes the Food and Drug Administration's continued ban on gay blood donations.
Shares of Agios Pharmaceuticals briefly popped more than 8 percent after reporting encouraging data on its lead drug.
The agreement calls for "coordination across a broad spectrum of public health issues" between the formerly bitter adversary nations.
Valeant rose about 3 percent in the premarket on the heels of CEO Joseph Papa buying a large amount of the company's stock.
Walgreens says it will close all 40 Theranos Wellness Centers and will no longer offer any Theranos services at any of its stores.
UnitedHealthcare will cover travel and lodging costs of donors, even if they aren't a customer.
Ren Xiaoping proposes using a glue to connect the spinal cord of the "healthy" head and a donor body, and volunteers are already queuing up.
Despite the drop in the use of painkillers by hurt workers, such medications remain commonly prescribed to them in many states.
Former employees of Insys Therapeutics were arrested for allegedly participating in kickback schemes involving doctors who prescribed the company's main drug, Subsys.
The expansion of Medicaid in many states has driven down the average amount of debt sent to collection agencies in many areas.
Bank of America CEO Brian Moynihan says employee wellness programs are a good investment. Here's how they're investing in employees—and saving money.
Get the best of CNBC in your inbox